期刊文献+
共找到12篇文章
< 1 >
每页显示 20 50 100
Co-Mo活性组分与加氢脱硫催化剂载体间相互作用的研究进展 被引量:5
1
作者 李佳佳 王广建 +2 位作者 陈晓婷 王芳 刘辉 《石化技术与应用》 CAS 2016年第5期433-438,共6页
综述了Co-Mo活性组分与加氢脱硫催化剂载体间相互作用的机理及研究进展,包括单组分载体、二元氧化物载体以及三元氧化物载体。认为活性组分在载体表面的分布状态及其与载体间的相互作用是影响催化剂活性与稳定性的关键因素。通过在单组... 综述了Co-Mo活性组分与加氢脱硫催化剂载体间相互作用的机理及研究进展,包括单组分载体、二元氧化物载体以及三元氧化物载体。认为活性组分在载体表面的分布状态及其与载体间的相互作用是影响催化剂活性与稳定性的关键因素。通过在单组分载体中添加助剂、制备多元氧化物载体等方法,可在一定程度上改善活性组分与载体间的相互作用。指出实现活性组分与载体间相互作用可控是未来研发新型加氢脱硫催化剂的方向。 展开更多
关键词 加氢脱硫 Co-Mo活性组分 催化剂载体 组分载体 二元氧化物载体 三元氧化物载体 负载量 相互作用
下载PDF
加氢脱硫催化剂载体的研究进展 被引量:16
2
作者 仝建波 蔺阳 +2 位作者 刘淑玲 温俊涛 刘瑛瑛 《化工进展》 EI CAS CSCD 北大核心 2014年第5期1170-1179,共10页
综述了加氢脱硫催化剂载体的研究现状及其发展趋势,分别从单组分载体、复合氧化物载体、分子筛和改性载体4个方面论述了加氢脱硫催化剂载体各自的优缺点。单组分载体重点介绍了A12O3、TiO2、炭载体;复合氧化物载体主要对铝基、钛基二元... 综述了加氢脱硫催化剂载体的研究现状及其发展趋势,分别从单组分载体、复合氧化物载体、分子筛和改性载体4个方面论述了加氢脱硫催化剂载体各自的优缺点。单组分载体重点介绍了A12O3、TiO2、炭载体;复合氧化物载体主要对铝基、钛基二元复合氧化物以及三元复合氧化物载体进行了综述;并且对以MCM-41、SBA-15和KIT为代表的介孔分子筛做了介绍;还描述了近年来以改性MCM-41、SBA-15、活性炭为主要研究对象的改性的分子筛。最后指出改性载体尤其是改性分子筛将是未来研究的焦点。 展开更多
关键词 加氢脱硫 催化剂载体 组分载体 复合氧化物载体 分子筛 改性载体
下载PDF
化妆品新型载体技术的应用进展 被引量:5
3
作者 杨佩 唐嘉雯 李雪竹 《日用化学品科学》 CAS 2021年第2期34-39,共6页
介绍了微海绵、葡糖微球、环糊精、液晶体系、超分子凝胶、聚合物胶束和化妆品贴剂等7种新型载体技术的组成、结构、性能以及在化妆品中的应用;提出了现阶段对于基础机理研究的不足,预测了化妆品新型载体技术的发展方向。
关键词 载体技术 载体组分 载体体系 化妆品
下载PDF
加氢脱硫催化剂载体的研究进展 被引量:4
4
作者 朱雪梅 纪晓飞 +1 位作者 丁保宏 臧树良 《广东化工》 CAS 2009年第9期84-85,101,共3页
文章阐述了近年来加氢脱硫催化剂载体的研究现状及其发展趋势。主要从单组分载体、复合氧化物载体和新型介孔分子筛三个方面详细论述了加氢脱硫催化剂载体研究进展。单组分载体重点介绍了A12O3、TiO2、ZrO2、活性炭;复合氧化物载体主要... 文章阐述了近年来加氢脱硫催化剂载体的研究现状及其发展趋势。主要从单组分载体、复合氧化物载体和新型介孔分子筛三个方面详细论述了加氢脱硫催化剂载体研究进展。单组分载体重点介绍了A12O3、TiO2、ZrO2、活性炭;复合氧化物载体主要对铝基复合物和钛基复合氧化物进行综述;并且以MCM-41和KIT为代表对新型介孔分子筛做了具体介绍。 展开更多
关键词 加氢脱硫 催化剂 组分载体 复合氧化物载体 介孔分子筛
下载PDF
人工病毒载体
5
作者 吴波 仲伯华 王嘉玺 《国外医学(药学分册)》 2002年第3期154-157,共4页
基因传递十分复杂 ,使用简单的载体分子难以完成。模拟病毒的重要性质 ,设计合成多组分载体。有些解决方法 ,如递送细胞锚定分子或正常功能的内源性核输入机制是直接拷贝自细菌和病毒的作用过程 ;另一些方法具有原创性 ,如由去污剂二聚... 基因传递十分复杂 ,使用简单的载体分子难以完成。模拟病毒的重要性质 ,设计合成多组分载体。有些解决方法 ,如递送细胞锚定分子或正常功能的内源性核输入机制是直接拷贝自细菌和病毒的作用过程 ;另一些方法具有原创性 ,如由去污剂二聚体化进行单分子基因组浓缩 ,或由质子吸附作用引发核内体的破裂 ,这些效应是天然的细胞侵袭者所不具备的。所有这些功能组分有待装配成一种独特的超分子系统 ,即“人工病毒”。 展开更多
关键词 人工病毒 基因传递 合成多组分载体 载体
下载PDF
Claus尾气加氢催化剂载体研究进展 被引量:2
6
作者 黄伟 王文年 +5 位作者 李飞 张勇 兰力强 侯鑫 孙权 满雪 《工业催化》 CAS 2014年第7期489-492,共4页
阐述了近年来Claus尾气加氢脱硫催化剂载体的研究现状。主要介绍了Al2O3和TiO2单组分载体及Al2O3-TiO2复合载体。Al2O3载体具有比表面积大、机械性能好和容易成型的特点,应用较广,但低温加氢活性较差;TiO2载体具有较高的低温加氢和有机... 阐述了近年来Claus尾气加氢脱硫催化剂载体的研究现状。主要介绍了Al2O3和TiO2单组分载体及Al2O3-TiO2复合载体。Al2O3载体具有比表面积大、机械性能好和容易成型的特点,应用较广,但低温加氢活性较差;TiO2载体具有较高的低温加氢和有机硫水解活性,但比表面积较小,一般以复合载体形式使用;复合载体具有较好的低温加氢活性和抗水性能,但制备工艺复杂。介孔结构不仅可以增大载体的比表面积,同时有利于分子的扩散,具有更加优异的活性。活性组分在复合载体表面呈现不同的活性状态,从而改变反应条件。如何调控Al2O3载体的孔道结构,研究复合载体各组分之间的作用及对活性组分的影响是今后的发展方向。 展开更多
关键词 催化剂工程 Claus尾气 加氢脱硫催化剂 组分载体 复合载体
下载PDF
通过疫苗开发控制细菌性传染病 被引量:1
7
作者 陈敏 《国外医学(预防.诊断.治疗用生物制品分册)》 2003年第3期100-104,共5页
需要开发能全球应用预防细菌性传染病的疫苗。这些疫苗应能廉价生产 ,在缺乏冷藏的条件下稳定 ,安全有效 ,能口服或鼻腔接种。
关键词 细菌性传染病 疫苗 开发 预防 活菌苗 抗原传递载体 质粒载体组分
下载PDF
Cloning the sterol carrier protein 2 genes of Japanese toad (Bufo japonicus formosus) and Chinese toad (Bufo gargarizans) and its tissue expression analysis 被引量:1
8
作者 Yu-Cheng JI Hui ZHUGE +2 位作者 Shan-Shan ZHANG Shu-Fang ZHANG Xian-Yu Yang 《Zoological Research》 CAS CSCD 北大核心 2014年第5期398-403,共6页
In this study,to clarify the bioactive polypeptides included in the skins and secretions of Bufo,we screened the Japanese toad(Bufo japonicus formosus) skin cDNA library by colony polymerase chain reaction(PCR),and ob... In this study,to clarify the bioactive polypeptides included in the skins and secretions of Bufo,we screened the Japanese toad(Bufo japonicus formosus) skin cDNA library by colony polymerase chain reaction(PCR),and obtained a transcript of 1 075 bp consisting of 1 37 bp 5′ untranslated region(UTR),515 bp 3′ UTR and a 423 bp open reading frame(ORF) encoding a polypeptide of 140 amino acid residues(GenBank accession number: KF359945).Homolog analysis showed a 70%–96% homology with sterol carrier protein-2(SCP-2) present in other animals,which is implicated in lipid metabolism of other organisms.The gene SCP-2 of Chinese toad(B.gargarizans) was cloned from a first strand cDNA of Bufo skin(GenBank accession number: KF381341) via PCR,whose encoding polypeptide has only one amino acid difference from that of Japanese toad.Tissue distribution analysis showed that SCP-2 expressed in all organs tested,though in the liver and spleen it manifested lower expression than in other organs.These findings might indicate SCP-2 being one of the active ingredients in toad skin.These findings may in turn have implications for further drug development from traditional Chinese medicine sources. 展开更多
关键词 Bufo gavgarizans Bufojaponicusformosus SCP-2 cDNA cloning Tissue expression
下载PDF
Pharmacokinetics and tissue distribution of intraperitoneal 5-fluorouracil with a novel carrier solution in rats 被引量:2
9
作者 Zhi-Gang Wei Guo-Xin Li Xiang-Cheng Huang Li Zhen Jiang Yu Hai-Jun Deng Shan-Hua Qing Ce Zhang 《World Journal of Gastroenterology》 SCIE CAS CSCD 2008年第14期2179-2186,共8页
AIM: To compare the pharmacokinetics and tissue distribution of 5-fluorouracil administered intraperitoneally with two isotonic carrier solutions: HAES-steri (neotype 6% hydroxyethyl starch), a novel carrier solution ... AIM: To compare the pharmacokinetics and tissue distribution of 5-fluorouracil administered intraperitoneally with two isotonic carrier solutions: HAES-steri (neotype 6% hydroxyethyl starch), a novel carrier solution with middle molecular weight and physiologic saline (0.9% sodium chloride solution), a traditional carrier solution for intraperitoneal chemotherapy, in rats. METHODS: A total of 60 Sprague Dawley rats were randomized into groups according to the carrier solution administered. Each group was further randomized according to the intraperitoneal dwell period (1, 3, 6, 12, 18 and 24 h). At the end of the procedure the rats were killed, the peritoneal fluid was withdrawn completely and quantitated. Drug concentrations in peritoneal fluid, plasma, and tissues were determined by high- performance liquid chromatography. RESULTS: The mean volumes remaining in the peritoneal cavity were significantly higher with HAES- steri than those with physiologic saline at 1, 6, 12, 18, and 24 h (P = 0.047, 0.009, 0.005, 0.005 and 0.005 respectively, the percentages of remaining peritoneal fluid volume were 89.9 ± 5.6 vs 83.4 ± 4.9, 79.9 ± 2.8 vs 56.2 ± 15.7, 46.8 ± 5.5 vs 24.7 ± 9.7, 23.0 ± 2.8 vs 0.0 ± 0.0 and 4.2 ± 1.7 vs 0.0 ± 0.0 respectively). Mean concentrations in peritoneal fluid were significantly higher with HAES-steri than those with physiologic saline at 3, 12 and 18 h (P = 0.009, 0.009 and 0.005 respectively, the concentrations were 139.2768 ± 28.2317 mg/L vs mg/L, 11.5427 ± 3.0976 mg/L vs 0.0000 ± 0.0000 mg/L and 4.7724 ± 1.0936 mg/L vs 0.0000 ± 0.0000 mg/L respectively). Mean plasma 5-fluorouracil concentrations in portal vein were significantly higher with HAES-steri at 3, 12, 18 and 24 h (P = 0.009, 0.034, 0.005 and 0.019 respectively, the concentrations were 3.3572 ± 0.8128 mg/L vs 0.8794 ± 0.2394 mg/L, 0.6203 ± 0.9935 mg/L vs 0.0112 ± 0.0250 mg/L, 0.3725 ± 0.3871 mg/L vs 0.0000 ± 0.0000 mg/L, and 0.2469 ± 0.1457 mg/L vs 0.0000 ± 0.0000 mg/L respectively), but significantly lower at 1 h (P = 0.009, the concentrations were 4.1957 ± 0.6952 mg/L vs 7.7406 ± 1.2377 mg/L). There were no significant differences in the plasma 5-fluorouracil in inferior caval vein at each time-point. 5-fluorouracil concentrations were significantly greater with HAES-steri at 18 h in gastric tissue (P = 0.016, the concentrations were 0.9486 ± 0.8173 mg/L vs 030392 ± 0.0316 mg/L), at 18 h in colon (P = 0.009, the concentrations were 0.1730 ± 0.0446 mg/L vs 0.0626 ± 0.0425 mg/L), at 3, 6, 12 and 24 h in liver (P = 0.009, 0.013, 0.034 and 0.013 respectively, the concentrations were 0.6472685 ± 0.5256 mg/L vs 0.1554 ± 0.1043mg/L, 0.8606826 ± 0.7155 mg/L vs 0.0014 ± 0.0029 mg/L, 0.0445 ± 0.0330 mg/L vs 0.0797 ± 0.1005 mg/L and 0.0863 ± 0.0399 mg/L vs 0.0034 ± 0.0075 mg/L respectively) and at 18 h in lung (P = 0.009, the concentrations were 0.0886 ± 0.0668 mg/L vs 0.0094 ± 0.0210 mg/L). There were no differences in 5-fluorouracil concentrations in renal tissue at each time-point. CONCLUSION: The use of intraperitoneal 5-fluoro- uracil with HAES-Steri carrier solution provides a pharmacokinetic advantage for a local-regional killing of residual tumor cells and improve the accumulated penetrability of 5-fluorouracil with decreased systemic toxicity. Further clinical feasibility studies on the use of HAES-steri as carrier solution for intraperitoneal chemotherapy with 5-fluorouracil are warranted. 展开更多
关键词 Carrier solutions Intraperitoneal chemo- therapy 5-FLUOROURACIL PHARMACOKINETICS Tissue distribution
下载PDF
Recombinant adenovirus-mediated expression of GHS-R1a in HEK 293 cells
10
作者 刘丽 徐华敏 +3 位作者 姜宏 王俊 宋宁 谢俊霞 《Neuroscience Bulletin》 SCIE CAS CSCD 2010年第3期225-231,共7页
Objective To construct the recombinant adenovirus vector carrying human growth hormone secretagogue receptor type 1a (GHS-R1a) ,for genetic transfection.Methods The full-length human GHS-R1a gene was obtained by PCR... Objective To construct the recombinant adenovirus vector carrying human growth hormone secretagogue receptor type 1a (GHS-R1a) ,for genetic transfection.Methods The full-length human GHS-R1a gene was obtained by PCR amplification and then cloned into the shuttle plasmid pAdTrack-CMV.The linearized plasmid pAdTrack-CMV-GHS-R1a was co-transformed into Escherichia coli (E.coli) BJ5183 cells along with an adenoviral backbone plasmid pAdEasy1.The HEK293 cells were then infected with adenoviruses.The expression of GHS-R1a was indicated by green fluorescent protein (GFP) ,and confirmed by Reverse Transcription Polymerase Chain Reaction (RT-PCR) and Western blot.Results Enzymatic digestion of pAdGHS-R1a yielded a large fragment (approximately 30 kb) and a small fragment (4.5 kb) ,indicating the success-ful construction of recombinant adenovirus expression vector.Expression of GFP was observed by confocal laser scanning microscopy at 24 h after infection.RT-PCR and Western blot further confirmed that GHS-R1a was efficiently expressed in 293 cells.Conclusion Recombinant adenovirus (AdGHS-R1a) is successfully constructed,and the target gene can be expressed efficiently in 293 cells,which provide a valuable tool for further studying the function of GHS-R1a. 展开更多
关键词 adenovirus vector homologous recombination GHS-R1a
原文传递
An efficient synthesis of polysubstituted tetrahydropyrimidines using acidic Al_2O_3 as solid media 被引量:1
11
作者 高天 季泠 +1 位作者 王欣 李润涛 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2016年第6期419-427,共9页
A series of polysubstituted tetrahydropyrimidines were synthesized in moderate to good yields via a one-pot, four-component reaction of an alkyne, formaldehyde, and amines in solid media acidic Al2O3. The advantages o... A series of polysubstituted tetrahydropyrimidines were synthesized in moderate to good yields via a one-pot, four-component reaction of an alkyne, formaldehyde, and amines in solid media acidic Al2O3. The advantages of this protocol include mild reaction conditions, broad substrate scope, and environmentally friendly reaction media. 展开更多
关键词 Tetrahydropyrimidine Solid media Acidic Al2O3 Multi-component reaction Green chemistry
原文传递
Assembly of long DNA sequences using a new synthetic Escherichia coli-yeast shuttle vector 被引量:3
12
作者 Zheng Hou Zheng Zhou +1 位作者 Zonglin Wang Gengfu Xiao 《Virologica Sinica》 SCIE CAS CSCD 2016年第2期160-167,共8页
Synthetic biology is a newly developed field of research focused on designing and rebuilding novel biomolecular components, circuits, and networks. Synthetic biology can also help understand biological principles and ... Synthetic biology is a newly developed field of research focused on designing and rebuilding novel biomolecular components, circuits, and networks. Synthetic biology can also help understand biological principles and engineer complex artificial metabolic systems. DNA manipulation on a large genome-wide scale is an inevitable challenge, but a necessary tool for synthetic biology. To improve the methods used for the synthesis of long DNA fragments, here we constructed a novel shuttle vector named p GF(plasmid Genome Fast) for DNA assembly in vivo. The BAC plasmid p CC1 BAC, which can accommodate large DNA molecules, was chosen as the backbone. The sequence of the yeast artificial chromosome(YAC) regulatory element CEN6-ARS4 was synthesized and inserted into the plasmid to enable it to replicate in yeast. The selection sequence HIS3, obtained by polymerase chain reaction(PCR) from the plasmid p BS313, was inserted for screening. This new synthetic shuttle vector can mediate the transformation-associated recombination(TAR) assembly of large DNA fragments in yeast, and the assembled products can be transformed into Escherichia coli for further amplification. We also conducted in vivo DNA assembly using p GF and yeast homologous recombination and constructed a 31-kb long DNA sequence from the cyanophage PP genome. Our findings show that this novel shuttle vector would be a useful tool for efficient genome-scale DNA reconstruction. 展开更多
关键词 yeast plasmid shuttle DNA recombination Genome assembly inserted amplification homologous
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部